Clinical Trial Update: APRIL (AbatacePt in Rheumatoid Arthritis-ILD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for APRIL (AbatacePt in Rheumatoid Arthritis-ILD) evaluating abatacept in rheumatoid arthritis with interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Rheumatoid Arthritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Rheumatoid Arthritis, Interstitial Lung Disease | Phase 2 | Status: UNKNOWN